Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients

Global Burden of Disease Cancer, 2018, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study, JAMA Oncol, 4, 1553, 10.1001/jamaoncol.2018.2706 Siegel, 2019, Cancer statistics, 2019, CA Cancer J Clin, 69, 7, 10.3322/caac.21551 Siegel, 2017, Cancer statistics, 2017, CA Cancer J Clin, 67, 7, 10.3322/caac.21387 Wang, 2016, Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients, Int J Cancer, 138, 2592, 10.1002/ijc.29991 Guan, 2010, Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy, BMC Cancer, 10, 431, 10.1186/1471-2407-10-431 Liu, 2017, Functional variants in DCAF4 associated with lung cancer risk in European populations, Carcinogenesis, 38, 541, 10.1093/carcin/bgx033 Xu, 2018, Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer, Int J Cancer, 143, 2400, 10.1002/ijc.31660 Chen, 2019, Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients, Int J Cancer, 145, 621, 10.1002/ijc.32128 Harrison, 2004, Gonadotropin-releasing hormone and its receptor in normal and malignant cells, Endocr Relat Cancer, 11, 725, 10.1677/erc.1.00777 Grundker, 2017, The role of gonadotropin-releasing hormone in cancer cell proliferation and metastasis, Front Endocrinol, 8, 187, 10.3389/fendo.2017.00187 Jayaram, 2016, Multi-omics data integration and mapping of altered kinases to pathways reveal gonadotropin hormone signaling in glioblastoma, Omics, 20, 736, 10.1089/omi.2016.0142 Stamatiades, 2019, GnRH—a key regulator of FSH, Endocrinology, 160, 57, 10.1210/en.2018-00889 Teng, 2015, Gonadotropinreleasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells, Mol Med Rep, 12, 4909, 10.3892/mmr.2015.4043 Limonta, 2012, GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies, Endocr Rev, 33, 784, 10.1210/er.2012-1014 Wang, 2017, SCF/C-Kit/JNK/AP-1 signaling pathway promotes claudin-3 expression in colonic epithelium and colorectal carcinoma, Int J Mol Sci, 18, 765, 10.3390/ijms18040765 Quang, 2015, The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells, Cell Death Dis, 6, e1658, 10.1038/cddis.2015.14 Najafi, 2019, Extracellular-signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) signaling as a target for cancer therapy: an updated review, Cell Biol Int, 1206, 10.1002/cbin.11187 Ruf, 2003, Structure of the GnRH receptor-stimulated signaling network: insights from genomics, Front Neuroendocrinol, 24, 181, 10.1016/S0091-3022(03)00027-X Yang, 2017, ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women, Oncotarget, 8, 10085, 10.18632/oncotarget.14341 Szatkowski, 2010, Inositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth, Mol Cancer, 9, 156, 10.1186/1476-4598-9-156 Hocking, 2010, Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, J Natl Cancer Inst, 102, 722, 10.1093/jnci/djq126 Tryka, 2014, NCBI's database of genotypes and phenotypes: dbGaP, Nucl Acids Res, 42, D975, 10.1093/nar/gkt1211 Mailman, 2007, The NCBI dbGaP database of genotypes and phenotypes, Nat Genet, 39, 1181, 10.1038/ng1007-1181 Zhai, 2014, Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease, Int J Cancer, 134, 961, 10.1002/ijc.28414 Aulchenko, 2007, GenABEL: an R library for genome-wide association analysis, Bioinformatics, 23, 1294, 10.1093/bioinformatics/btm108 Benjamini, 2001, Controlling the false discovery rate in behavior genetics research, Behav Brain Res, 125, 279, 10.1016/S0166-4328(01)00297-2 Wakefield, 2007, A Bayesian measure of the probability of false discovery in genetic epidemiology studies, Am J Hum Genet, 81, 208, 10.1086/519024 Chambless, 2006, Estimation of time-dependent area under the ROC curve for long-term risk prediction, Stat Med, 25, 3474, 10.1002/sim.2299 Nica, 2013, Expression quantitative trait loci: present and future, Philos Trans R Soc Lond B Biol Sci, 368, 10.1098/rstb.2012.0362 Lappalainen, 2013, Transcriptome and genome sequencing uncovers functional variation in humans, Nature, 501, 506, 10.1038/nature12531 Consortium, 2015, Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans, Science, 348, 648, 10.1126/science.1262110 Fen, 1993, Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor, Biochemistry, 32, 7932, 10.1021/bi00082a014 Higashiyama, 1991, A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF, Science, 251, 936, 10.1126/science.1840698 Besner, 1990, Isolation and characterization of a macrophage-derived heparin-binding growth factor, Cell Regul, 1, 811, 10.1091/mbc.1.11.811 Yang, 2014, Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: application and future prospects, Pathophysiology, 21, 95, 10.1016/j.pathophys.2013.11.008 Mishima, 1998, Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas, Acta Neuropathol, 96, 322, 10.1007/s004010050901 Kobrin, 1994, Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer, Biochem Biophys Res Commun, 202, 1705, 10.1006/bbrc.1994.2131 Tanaka, 2005, Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer, Clin Cancer Res, 11, 4783, 10.1158/1078-0432.CCR-04-1426 Miyata, 2017, Serum heparin-binding epidermal growth factor-like growth factor (HB-EGF) as a biomarker for primary ovarian cancer, Anticancer Res, 37, 3955 Hsieh, 2017, A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer, Oncogene, 36, 2946, 10.1038/onc.2016.465 Barski, 2007, High-resolution profiling of histone methylations in the human genome, Cell, 129, 823, 10.1016/j.cell.2007.05.009 Shibao, 2010, The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma, Cell Calcium, 48, 315, 10.1016/j.ceca.2010.09.005 Rezuchova, 2019, Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells, Cell Death Dis, 10, 186, 10.1038/s41419-019-1433-4 Kuchay, 2017, PTEN counteracts FBXL2 to promote IP3R3- and Ca(2+)-mediated apoptosis limiting tumour growth, Nature, 546, 554, 10.1038/nature22965